https://jctei.com/index.php/jctei/issue/feedJournal of Clinical Trials and Experimental Investigations2024-10-28T22:47:36+03:00Editor/ Prof. Dr. Mehmet Hanifi Okureditor@jctei.comOpen Journal Systems<p>The <strong>“Journal of Clinical Trials and Experimental Investigations (Abbreviation: J Clin Trials Exp Investig)" (e-ISSN 2822-5090)</strong> is an independent, quarterly, peer-reviewed, double-blind, open-access international general medical journal founded in January 2022. It is published four times a year (March, June, September, and December). This journal publishes Original Articles, Reviews, Short communications, Case reports, Letters to the Editor, Opinion papers, Technical notes, and Editorials. Articles are selected and published following a rigorous analysis, according to internationally accepted standards. The journal is open to scholars, as well as all members of the medical community, expressing interest in using this forum to publish their work. No fee is charged from the authors during the article evaluation and publication process. The Journal of Clinical Trials and Experimental Investigations is the official journal of the Silvan Academy of Surgery. The journal is non-profit and doesn't accept advertisements. The official language is English.</p>https://jctei.com/index.php/jctei/article/view/141Artificial intelligence and robotic surgery in colorectal cancer surgery2024-10-28T22:47:36+03:00Ismail Ahmet Bilginahmetbilginbilgin@gmail.comAskin Kadir Percemyazar@jctei.comOrhan Aslandrorhanaslan@gmail.com2024-09-30T00:00:00+03:00Copyright (c) 2024 Journal of Clinical Trials and Experimental Investigationshttps://jctei.com/index.php/jctei/article/view/126Cardiometabolic risk estimation in professional firefighters2024-09-27T19:29:32+03:00Javier Lucas Tosorattojavierlucastosoratto@gmail.comBarbara Carriedoyazar@jctei.comAna Cecilia Romeroanaceciliaromeroaguirre@gmail.comMaria Banegilmariabegilarroyo@gmail.comÁngel Arturo López Gonzálezangarturo@gmail.comHector Eugercioshectoreugercios@gmail.com<p><strong>Objective: </strong>Cardiometabolic diseases are currently the leading causes of morbidity and mortality worldwide and are highly prevalent. Firefighters, due to the nature of their work, appear to have a high prevalence of these pathologies. Our objective was to determine the prevalence of variables related to cardiometabolic risk in a group of professional firefighters.</p> <p><strong>Materials and methods: </strong>A descriptive, cross-sectional study was performed in 2155 Spanish firefighters between January 2019 and December 2019. Body mass index (BMI) and CUN BAE (Body Adiposity Estimator from the University Clinic of Navarra) were evaluated.</p> <p><strong>Results: </strong>The study evaluated cardiometabolic risk factors among 2,127 firefighters, showing that 29.71% (n=632) were smokers, 27.7% (n=589) were sedentary, and 36.06% (n=767) did not follow a Mediterranean diet. The prevalence of hypertension increased with age: 14.75% (n=96) among those under 40, 19.71% (n=176) in those aged 40-49, and 39.97% (n=233) in those over 50. Total cholesterol ≥ 200 mg/dL was found in 48.47% (n=1,030), with LDL-c ≥ 130 mg/dL in 37.09% (n=789). Metabolic syndrome according to NCEP ATPIII criteria was present in 8.65% (n=184), while atherogenic dyslipidemia was noted in 3.43% (n=73).</p> <p><strong>Conclusions: </strong>Considering that the average age of our sample is not very high, the cardiometabolic risk in our group of firefighters can be classified as elevated.</p> <p><strong>Level of evidence:</strong> Level IIb</p>2024-09-30T00:00:00+03:00Copyright (c) 2024 Journal of Clinical Trials and Experimental Investigationshttps://jctei.com/index.php/jctei/article/view/115Perioperative findings and long-term impact of urinary bladder injuries secondary to cesarean delivery: A retrospective analysis of 67 cases2024-08-01T13:50:15+03:00Adem Tuncekindr_adem65@hotmail.comMehmet Yigit Yalcinyigityalcin@hotmail.com<p><strong>Objective</strong><strong>:</strong> The urinary bladder injury after cesarean delivery is rare but significant. Our study aimed to identify significant perioperative findings in bladder injuries secondary to cesarean delivery and assess their long-term impact on bladder functions.</p> <p><strong>Materials and methods</strong><strong>:</strong> In this retrospective study, we reviewed 67 patients with bladder injuries from cesarean deliveries treated at our hospital between September 2018 and February 2023. The study included only cases involving surgical repair of these injuries related to cesarean delivery. Data were collected on patient demographics, medical and surgical history, injury details, treatment methods, and postoperative outcomes, including bladder function assessments and complications within a year after surgery.</p> <p><strong>Results</strong><strong>:</strong> Between September 2018 and February 2023, 123.296 pregnant women were admitted to our hospital for birth; 46.786 (38%) cesarean deliveries occurred, and 67 (0.14%) patients suffered bladder injuries. Diagnosis was made intraoperatively in 58 (86.56%) patients and postoperatively in 9 (13.43%) patients. The mean age of the patients was 33.8±5.08 years and the mean number of cesarean sections the patients had undergone was 3.25±1.23. The mean bladder defect size was 4.46±2.91 cm, and they were most frequently observed in the bladder dome. Lower urinary tract symptoms were observed in 4 (5.97%) patients in the early period (postoperative 1st month) and in 12 (17.91%) patients in the late period (after 1st month), and the most common symptom was dysuria.</p> <p><strong>Conclusions:</strong> Bladder injury during cesarean delivery is a rare but serious condition. Immediate repair is crucial when the injury is visible. Any suspected injury in the postoperative period should prompt diagnostic procedures and subsequent treatment without delay. Regular follow-up appointments are essential for monitoring postoperative complications and bladder functions.</p>2024-09-20T00:00:00+03:00Copyright (c) 2024 Journal of Clinical Trials and Experimental Investigationshttps://jctei.com/index.php/jctei/article/view/127Prevalence of isolated systolic and diastolic hypertension and its relathionship with sociodemographic variables and healthy habits in 193,462 spanish workers2024-10-01T21:19:44+03:00Rosa González Casqueroyazar@jctei.comÁngel Arturo López Gonzálezangarturo@gmail.comJuan Antonio Roberto Martinjuanantonio.roberto@ssib.esElisa Leal Matillaelisa.leal@hsll.esMaría del Mar Diviesomar-divieso@hotmail.comMaría Gil-Llinásyazar@jctei.com<p><strong>Objective: </strong>Hypertension (HTN) is one of the leading risk factors for cardiovascular diseases, contributing significantly to the global burden of morbidity and mortality. Among the different types of hypertension, isolated systolic hypertension (ISH) and isolated diastolic hypertension (IDH) are distinguished, both with particular clinical implications. The aim of this study is to assess how certain sociodemographic variables and healthy habits influence the prevalence of ISH and IDH.</p> <p><strong>Material and methods: </strong>A descriptive, cross-sectional study of 193,462 Spanish workers, evaluating the influence of age, gender, social class, educational level, tobacco consumption, physical exercise, and adherence to the Mediterranean diet on the prevalence of ISH and IDH.</p> <p><strong>Results: </strong>The prevalence of ISH increases with age, in men, in individuals of lower social and educational levels, and in those who are sedentary. The prevalence of IDH is higher in men, individuals with lower socioeconomic status, those who are sedentary, and those with low adherence to the Mediterranean diet (p<0.05 for each comparison).</p> <p><strong>Conclusion: </strong>Both ISH and IDH are influenced by male gender, sedentary lifestyle, and low socioeconomic status. Advanced age is a factor in ISH, while low adherence to the Mediterranean diet influences IDH.</p>2024-09-30T00:00:00+03:00Copyright (c) 2024 Journal of Clinical Trials and Experimental Investigationshttps://jctei.com/index.php/jctei/article/view/118Lichenoid drug eruption due to pirfenidone in a patient with idiopathic pulmonary fibrosis2024-09-22T23:18:16+03:00Mehmet Semih Celikdrmsemihcelik@gmail.comCandan Celikcandancelik@gmail.comNagehan Cepikharuncan0104@gmail.comMehmet Selcuk Ozercanozercanms2323@gmail.com<p>Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease of unknown cause characterized by relentless scarring in the lung parenchyma, leading to decreased quality of life and early mortality. Pirfenidone and nintedanib have been approved for the treatment of IPF based on their ability to slow functional decline and disease progression. Lichenoid drug eruption (LDE) refers to a drug-induced eruption resembling lichen planus, typically presenting as purple, symmetrical, eczematous plaques. While skin reactions due to pirfenidone have been reported in numerous cases, pirfenidone-induced LDE is rarely observed. In this case, we present a rare instance of pirfenidone-induced LDE.</p>2024-09-20T00:00:00+03:00Copyright (c) 2024 Journal of Clinical Trials and Experimental Investigations